DNA damage response and DDB

DNA损伤反应和DDB

基本信息

  • 批准号:
    7603020
  • 负责人:
  • 金额:
    $ 28.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-05-15 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): DNA damage in somatic cells is one of the main causes of aging and many age-related diseases, including cancer and decreased tissue regeneration. Cells respond to DNA damage by triggering the checkpoint pathways that delay the cell cycle progression allowing time for DNA repair. The checkpoint pathway involves association of the PI3 kinases ATM/ATR with damaged chromatin and subsequent activation of the checkpoint kinases (Chk1 and Chk2) and p53, as well as other regulatory proteins that control the fate of a cell following DNA damage. Despite significant advances on the damage-response pathways, the mechanisms (sensors) that recruit ATM/ATR to damaged-DNA are not known. Our recent studies revealed that the damaged-DNA binding protein DDB functions as a damage-sensor that recruits ATR to the UV-damaged chromatin to activate the ATR-Chk1/p53 pathway. The objectives of this proposal are to further investigate the damage-sensor function of DDB and determine the spectrum of DNA damage for which DDB functions as a sensor leading to the activation of the ATR-checkpoint pathway. DDB is composed to two subunits: DDB1 and DDB2. The DDB2 subunit is transcriptionally induced by p53 upon DNA damage. We will test the hypothesis that the p53-induced expression of DDB2 is critical for a sustained activation of the checkpoints following DNA damage. Also, we plan to develop a knockout strain of mice lacking DDB1 to investigate the functions of DDB1 in a physiological context. Accumulating evidence indicates that the DDB1 subunit possesses functions that are independent of the DDB2 subunit. For example, DDB1 has been shown to be involved in the proteolysis of c-jun in conjunction with cullin 4A. Also, the fission yeast ortholgue of DDB1 has been implicated in the proteolysis through the ubiquitin-proteasome pathway. A conditional knockout strain of mice will be important in evaluating the various functions of DDB1 in a physiological context. The specific aims are: 1. Does DDB function as a sensor for a wide range of DNA damages? Is the DDB-mediated activation of ATR-Chk1 linked to initiation of DNA replication? Does the DDB-mediated activation of ATR-Chk1 involve chromatin-remodeling by CBP/p300? 2.Does DDB play a role in the sustained activation of checkpoints following DNA damage? Does DNA damage-induced senescence depend upon DDB? 3. What are the in vivo functions of DDB1?
描述(由申请人提供):体细胞中的DNA损伤是衰老和许多与年龄有关的疾病的主要原因之一,包括癌症和组织再生。细胞通过触发延迟细胞周期进程的检查点途径来应对DNA损伤,从而允许DNA修复时间。检查点途径涉及将PI3激酶ATM/ATR与染色质受损的关联以及随后的检查点激酶(CHK1和CHK2)和p53的激活,以及其他调节蛋白,这些调节蛋白控制DNA损伤后细胞的命运。尽管损伤响应途径取得了重大进展,但尚不清楚将ATM/ATR募集到损坏的DNA的机制(传感器)。 我们最近的研究表明,受损的DNA结合蛋白DDB充当损伤传感器,可募集ATR到UV受损的染色质中,以激活ATR-CHK1/p53途径。该建议的目标是进一步研究DDB的损伤传感器功能,并确定DNA损伤的频谱DDB充当传感器,导致ATR-Checkpoint途径的激活。 DDB组成两个亚基:DDB1和DDB2。 DDB2亚基是在DNA损伤后通过p53转录诱导的。 我们将测试以下假设:p53诱导的DDB2表达对于DNA损伤后的检查点的持续激活至关重要。此外,我们计划开发缺乏DDB1的小鼠的敲除菌株,以研究生理环境中DDB1的功能。积累的证据表明DDB1亚基具有与DDB2亚基无关的功能。例如,DDB1已显示与C-Jun与Cullin 4A结合使用。同样,DDB1的裂变酵母正矫正与通过泛素 - 蛋白酶体途径的蛋白水解有关。 小鼠的条件敲除菌株对于在生理环境中评估DDB1的各种功能将很重要。具体目的是: 1。DDB是否充当多种DNA损伤的传感器? DDB介导的ATR-CHK1的激活是否与DNA复制的启动有关? DDB介导的ATR-CHK1激活是否涉及CBP/P300的染色质复制? 2. DYES DDB在DNA损伤后的检查点的持续激活中起作用吗? DNA损伤引起的衰老是否取决于DDB? 3。DDB1的体内功能是什么?

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis.
  • DOI:
    10.1016/j.virol.2009.10.018
  • 发表时间:
    2010-01-05
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Oh, Kwang-Jin;Kalinina, Anna;Bagchi, Srilata
  • 通讯作者:
    Bagchi, Srilata
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pradip Raychaudhuri其他文献

Pradip Raychaudhuri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pradip Raychaudhuri', 18)}}的其他基金

Repression function of FoxM1 in metastasis
FoxM1在转移中的抑制功能
  • 批准号:
    9910845
  • 财政年份:
    2019
  • 资助金额:
    $ 28.05万
  • 项目类别:
Repression function of FoxM1 in metastasis
FoxM1在转移中的抑制功能
  • 批准号:
    10229508
  • 财政年份:
    2019
  • 资助金额:
    $ 28.05万
  • 项目类别:
Repression function of FoxM1 in metastasis
FoxM1在转移中的抑制功能
  • 批准号:
    10020378
  • 财政年份:
    2019
  • 资助金额:
    $ 28.05万
  • 项目类别:
Repression function of FoxM1 in metastasis
FoxM1在转移中的抑制功能
  • 批准号:
    10460966
  • 财政年份:
    2019
  • 资助金额:
    $ 28.05万
  • 项目类别:
Repression function of FoxM1 in metastasis
FoxM1在转移中的抑制功能
  • 批准号:
    10670759
  • 财政年份:
    2019
  • 资助金额:
    $ 28.05万
  • 项目类别:
FoxM1 in liver cancer.
FoxM1 在肝癌中的作用。
  • 批准号:
    8787994
  • 财政年份:
    2014
  • 资助金额:
    $ 28.05万
  • 项目类别:
FoxM1 in breast cancer.
FoxM1 在乳腺癌中的作用。
  • 批准号:
    8848358
  • 财政年份:
    2014
  • 资助金额:
    $ 28.05万
  • 项目类别:
FoxM1 in breast cancer.
FoxM1 在乳腺癌中的作用。
  • 批准号:
    9251769
  • 财政年份:
    2014
  • 资助金额:
    $ 28.05万
  • 项目类别:
FoxM1 in tumor cell
肿瘤细胞中的 FoxM1
  • 批准号:
    9339464
  • 财政年份:
    2009
  • 资助金额:
    $ 28.05万
  • 项目类别:
FoxM1 in tumor cell
肿瘤细胞中的 FoxM1
  • 批准号:
    10004294
  • 财政年份:
    2009
  • 资助金额:
    $ 28.05万
  • 项目类别:

相似海外基金

DNA damage response and DDB
DNA损伤反应和DDB
  • 批准号:
    7228937
  • 财政年份:
    2005
  • 资助金额:
    $ 28.05万
  • 项目类别:
DNA damage response and DDB
DNA损伤反应和DDB
  • 批准号:
    7415137
  • 财政年份:
    2005
  • 资助金额:
    $ 28.05万
  • 项目类别:
Studies of Non-Ionizing Radiation-Related Cancer
非电离辐射相关癌症的研究
  • 批准号:
    7966617
  • 财政年份:
  • 资助金额:
    $ 28.05万
  • 项目类别:
Studies of Non-Ionizing Radiation-Related Cancer
非电离辐射相关癌症的研究
  • 批准号:
    7733709
  • 财政年份:
  • 资助金额:
    $ 28.05万
  • 项目类别:
Studies of Non-Ionizing Radiation-Related Cancer
非电离辐射相关癌症的研究
  • 批准号:
    7593175
  • 财政年份:
  • 资助金额:
    $ 28.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了